We are live on ! Find out more
MDSL

M.D. Sass LLC Portfolio holdings

AUM $1.32B
1-Year Est. Return 16.01%
This Fund
S&P 500
This Quarter Est. Return
-5.02%
1 Year Est. Return
+16.01%
3 Year Est. Return
+54.62%
5 Year Est. Return
+70.79%
10 Year Est. Return
+248.43%
AUM
$545M
AUM Growth
+$16.2M
Cap. Flow
+$51.4M
Cap. Flow %
9.42%
Top 10 Hldgs %
54.95%
Holding
35
New
6
Increased
13
Reduced
9
Closed
4

Sector Composition

Rank Sector Weight
1 Industrials 18.91%
2 Financials 18.43%
3 Communication Services 15.79%
4 Technology 13.06%
5 Healthcare 12.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
26
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$2.59M 0.48%
7,262
ACWX icon
27
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$1.27M 0.23%
31,800
TZA icon
28
Direxion Daily Small Cap Bear 3x ETF
TZA
$213M
$1.11M 0.2%
2,423
+1,430
+144% +$524K
NSLR
29
Neostellar Capital Corp
NSLR
$262M
$946K 0.17%
244,348
+20,000
+9% +$122K
SJB icon
30
ProShares Short High Yield
SJB
$52.1M
$875K 0.16%
43,713
OPCH icon
31
Option Care Health
OPCH
$3.4B
$302K 0.06%
9,591
-5,435
-36% -$174K
BC icon
32
Brunswick
BC
$5.19B
-159,601
Closed -$10.4M
PWR icon
33
Quanta Services
PWR
$93.9B
-141,336
Closed -$17.7M
SPXS icon
34
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$332M
-3,323
Closed -$886K
VRTX icon
35
Vertex Pharmaceuticals
VRTX
$121B
-77,059
Closed -$21.7M

Similar funds

M.D. Sass LLC's Q3 2022 Portfolio in Review

As of Q3 2022, M.D. Sass LLC held 35 positions worth $545M, up 3.1% from $529M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

M.D. Sass LLC deployed $51.4M of net new capital in Q3 2022, opening 6 new positions and adding to 13 existing holdings. Its largest new stake was Charles River Laboratories: 138,414 shares worth $27.2M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 23% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was ON Semiconductor, an estimated $14.9M trimmed.

  • M.D. Sass LLC's largest Q3 2022 buy was Charles River Laboratories: 138,414 shares worth $27.2M.
  • M.D. Sass LLC added most to CACI in Q3 2022, an estimated $10.8M increase.
  • M.D. Sass LLC's biggest Q3 2022 reduction was ON Semiconductor, cutting an estimated $14.9M.
  • M.D. Sass LLC fully exited Vertex Pharmaceuticals in Q3 2022, selling an estimated $21.7M.
  • M.D. Sass LLC's ten largest holdings make up 55% of its $545M portfolio in Q3 2022.
  • M.D. Sass LLC opened 6 new positions and closed 4 in Q3 2022.
  • M.D. Sass LLC's portfolio value rose 3.1% quarter-over-quarter to $545M.

Based on M.D. Sass LLC's 13F filing for Q3 2022, filed 15 Nov 2022.